Neural mechanism of the relationship between sleep efficiency and clinical improvement in major depressive disorder: A longitudinal functional magnetic resonance imaging study.

Tao Chen, Wenming Zhao, Yu Zhang, Jiakuai Yu, Ting Wang, Jiajia Zhang, Yifei Li, Jiajia Zhu, Dao-Min Zhu
Author Information
  1. Tao Chen: Department of Sleep Disorders, Affiliated Psychological Hospital of Anhui Medical University, Hefei, China.
  2. Wenming Zhao: Department of Radiology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
  3. Yu Zhang: Department of Sleep Disorders, Affiliated Psychological Hospital of Anhui Medical University, Hefei, China.
  4. Jiakuai Yu: Department of Sleep Disorders, Affiliated Psychological Hospital of Anhui Medical University, Hefei, China.
  5. Ting Wang: Department of Sleep Disorders, Affiliated Psychological Hospital of Anhui Medical University, Hefei, China.
  6. Jiajia Zhang: Department of Sleep Disorders, Affiliated Psychological Hospital of Anhui Medical University, Hefei, China.
  7. Yifei Li: Department of Sleep Disorders, Affiliated Psychological Hospital of Anhui Medical University, Hefei, China.
  8. Jiajia Zhu: Department of Radiology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
  9. Dao-Min Zhu: Department of Sleep Disorders, Affiliated Psychological Hospital of Anhui Medical University, Hefei, China.

Abstract

Background: Antidepressants represent the most common treatment of choice for major depressive disorder (MDD). In this study, we aimed to explore the status-related changes (acute vs. remitted status) in brain function in patients with MDD.
Methods: Regular antidepressant medications (an average of 7 months after the initial visit, remitted status) were received by 48 patients with MDD. All the patients underwent MRI and polysomnography examinations as well as clinical assessment at each visit.
Results: We found that baseline fractional amplitude of low-frequency fluctuations (fALFF) of right superior parietal gyrus (SPG) and middle frontal gyrus could predict depression and anxiety symptoms improvement from acute to remitted status in patients with MDD, respectively. Moreover, we found a significant positive correlation between the fALFF of right SPG and baseline sleep efficiency (SE) in patients with MDD. Further mediation analysis revealed that the fALFF of right SPG mediated the relationship between baseline SE and depressive symptom improvement.
Conclusion: Apart from highlighting the fALFF as a potential prognostic indicator to predict and track disease progression in patients with MDD, these findings might provide a neural mechanism basis for improving sleep quality of patients with MDD and thus promoting the recovery of clinical symptoms, as well as provide a practical basis for clinical interventions in patients with MDD with sleep disorders.

Keywords

References

  1. Lancet. 2018 Nov 24;392(10161):2299-2312 [PMID: 30396512]
  2. Lancet. 2013 Nov 9;382(9904):1575-86 [PMID: 23993280]
  3. Occup Med (Lond). 2015 Oct;65(7):601 [PMID: 26370845]
  4. Sleep. 2013 Nov 01;36(11):1747-55 [PMID: 24179309]
  5. Am J Psychiatry. 2021 Oct 1;178(10):896-902 [PMID: 34592843]
  6. Lancet. 2018 Apr 7;391(10128):1357-1366 [PMID: 29477251]
  7. Psychol Med. 2017 Feb;47(3):438-450 [PMID: 27697079]
  8. Front Psychiatry. 2020 Jan 23;10:1021 [PMID: 32038338]
  9. J Affect Disord. 2010 Dec;127(1-3):19-30 [PMID: 20884063]
  10. JAMA Psychiatry. 2018 Oct 1;75(10):1052-1061 [PMID: 30046833]
  11. Front Psychiatry. 2018 Dec 04;9:651 [PMID: 30564152]
  12. J Affect Disord. 2020 Nov 1;276:822-828 [PMID: 32738667]
  13. Sleep. 2008 Feb;31(2):283-91 [PMID: 18274276]
  14. Psychiatry Res. 1989 May;28(2):193-213 [PMID: 2748771]
  15. Am J Psychiatry. 2007 May;164(5):739-52 [PMID: 17475733]
  16. Biol Psychiatry. 1996 Mar 15;39(6):411-8 [PMID: 8679786]
  17. Neuroinformatics. 2016 Jul;14(3):339-51 [PMID: 27075850]
  18. Depress Anxiety. 2003;18(2):53-61 [PMID: 12964171]
  19. Psychol Med. 2022 Apr 01;:1-14 [PMID: 35362398]
  20. J Affect Disord. 2020 Apr 1;266:327-337 [PMID: 32056895]
  21. Transl Psychiatry. 2020 Dec 8;10(1):425 [PMID: 33293520]
  22. J Neurosci Methods. 2008 Jul 15;172(1):137-41 [PMID: 18501969]
  23. Transl Psychiatry. 2019 Dec 9;9(1):335 [PMID: 31819044]
  24. J Affect Disord. 2016 Jan 15;190:880-888 [PMID: 26639452]
  25. Arch Gen Psychiatry. 1988 Aug;45(8):742-7 [PMID: 3395203]
  26. Clin Psychol Rev. 2018 Jul;63:25-40 [PMID: 29879564]
  27. Hum Brain Mapp. 2017 Oct;38(10):4996-5018 [PMID: 28653792]
  28. J Affect Disord. 2015 Apr 1;175:441-5 [PMID: 25679198]
  29. Metab Brain Dis. 2017 Feb;32(1):147-154 [PMID: 27524655]
  30. Cereb Cortex. 2009 Apr;19(4):805-19 [PMID: 18689860]
  31. Cell Biochem Biophys. 2013 Jun;66(2):347-50 [PMID: 23076639]
  32. Nat Genet. 2019 Mar;51(3):394-403 [PMID: 30804565]
  33. J Psychosoc Nurs Ment Health Serv. 2011 Jan;49(1):17-20 [PMID: 21175118]
  34. J Affect Disord. 2019 Feb 1;244:92-99 [PMID: 30326347]
  35. Neuropsychiatr Dis Treat. 2014 Jan 30;10:201-16 [PMID: 24511235]
  36. Arch Gen Psychiatry. 1992 Oct;49(10):809-16 [PMID: 1417434]
  37. Magn Reson Med. 1995 Oct;34(4):537-41 [PMID: 8524021]
  38. Sleep Med. 2017 Apr;32:97-104 [PMID: 28366349]
  39. J Clin Sleep Med. 2016 Feb;12(2):263-6 [PMID: 26194727]
  40. J Affect Disord. 2022 Jan 1;296:400-407 [PMID: 34606812]
  41. BMJ Open. 2016 Jan 04;6(1):e007919 [PMID: 26729376]
  42. J Clin Psychiatry. 2005 Oct;66(10):1254-69 [PMID: 16259539]
  43. Brain Dev. 2007 Mar;29(2):83-91 [PMID: 16919409]
  44. Metab Brain Dis. 2017 Jun;32(3):891-901 [PMID: 28299626]
  45. Asia Pac Psychiatry. 2014 Jun;6(2):152-60 [PMID: 23857869]
  46. J Affect Disord. 2021 Dec 1;295:1057-1065 [PMID: 34706414]
  47. Neuroimage. 2007 Oct 15;38(1):95-113 [PMID: 17761438]
  48. J Abnorm Psychol. 2015 Aug;124(3):463-75 [PMID: 25894440]
  49. J Affect Disord. 2011 Dec;135(1-3):10-9 [PMID: 21300408]
  50. Am J Psychiatry. 2006 Nov;163(11):1905-17 [PMID: 17074942]
  51. J Clin Psychiatry. 2012 Sep;73(9):e1160-7 [PMID: 23059158]
  52. J Affect Disord. 2013 Dec;151(3):1097-101 [PMID: 24074717]
  53. Am J Epidemiol. 1997 Jul 15;146(2):105-14 [PMID: 9230772]
  54. J Psychosom Res. 2018 Mar;106:1-12 [PMID: 29455893]
  55. J Affect Disord. 2013 Apr 5;146(2):197-204 [PMID: 23021193]
  56. Psychol Methods. 2011 Jun;16(2):93-115 [PMID: 21500915]
  57. Front Psychiatry. 2018 Mar 20;9:93 [PMID: 29615938]
  58. J Cell Mol Med. 2019 Apr;23(4):2324-2332 [PMID: 30734486]

Word Cloud

Created with Highcharts 10.0.0MDDpatientsclinicalsleepdepressivefALFFmajorremittedstatusbaselinerightSPGsymptomsimprovementefficiencydisorderstudyacutevisitpolysomnographywellfoundgyruspredictSErelationshipprovidemechanismbasisfunctionalmagneticresonanceimagingBackground:Antidepressantsrepresentcommontreatmentchoiceaimedexplorestatus-relatedchangesvsbrainfunctionMethods:Regularantidepressantmedicationsaverage7monthsinitialreceived48underwentMRIexaminationsassessmentResults:fractionalamplitudelow-frequencyfluctuationssuperiorparietalmiddlefrontaldepressionanxietyrespectivelyMoreoversignificantpositivecorrelationmediationanalysisrevealedmediatedsymptomConclusion:AparthighlightingpotentialprognosticindicatortrackdiseaseprogressionfindingsmightneuralimprovingqualitythuspromotingrecoverypracticalinterventionsdisordersNeuraldisorder:longitudinal

Similar Articles

Cited By